Baidu
map

美国临床试验数据库(ClinicalTrials)注册流程与填写要求

2014-03-03 王洋,雷燕 中国中医药信息杂志

  临床试验注册制度,指在临床试验实施前就在公共数据库公开试验设计信息,并跟踪和报告试验结果。临床试验注册制度不仅有利于增加临床试验信息的 透明度、减少发表偏倚,更有利于保障临床试验质量、增加试验过程的规范性和试验结果的可信度,已成为当今临床试验发展的主流趋势[1-2]。  我国中医药领域对临床试验注册的重视程度和实践情况不容乐观,以美国临床试验数据库(ClinicalTrials.gov)

  临床试验注册制度,指在临床试验实施前就在公共数据库公开试验设计信息,并跟踪和报告试验结果。临床试验注册制度不仅有利于增加临床试验信息的 透明度、减少发表偏倚,更有利于保障临床试验质量、增加试验过程的规范性和试验结果的可信度,已成为当今临床试验发展的主流趋势[1-2]。  我国中医药领域对临床试验注册的重视程度和实践情况不容乐观,以美国临床试验数据库(ClinicalTrials.gov)为例,截止 2012年4月,共有170多个国家和地区的超过12万项临床试验在其数据库注册,而中医药相关的临床试验只有200余项,在这200余项中,由中国大陆 注册的仅不到半数[3],这种情况不利于中医临床试验的发展和与时俱进,亟需中医药科研人员加以重视。目前,国际上重要的临床试验注册机构有 ClinicalTrials.gov、英国国立研究注册库(NRR)、世界卫生组织临床试验注册平台(ICTRP)等。本文就 ClinicalTrials.gov临床试验方案注册的流程和信息填写要求等作一介绍,希望对中医药临床科研人员有所启发。  1 简介  ClinicalTrials.gov是美国国立医学图书馆(

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (22)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2023-09-26 kobchenl 来自北京

    哇塞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2023-09-26 kobchenl 来自北京

    1

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2023-09-26 kobchenl 来自北京

    1

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2016-03-20 limuhan

    很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2016-03-20 limuhan

    很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2016-03-20 limuhan

    很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2016-02-25 cmn

    谢谢啦

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2016-02-17 research_2015

    学习了,谢谢!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2016-01-08 vv79

    很好,领导让学习,谢谢!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2159756, encodeId=85702159e56d8, content=哇塞, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:05:28 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159753, encodeId=a2392159e5331, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:33 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2159752, encodeId=1bef2159e52bb, content=1, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6f05518516, createdName=kobchenl, createdTime=Tue Sep 26 09:02:07 CST 2023, time=2023-09-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=72023, encodeId=b0c1e2023e8, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72024, encodeId=df07e202459, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72022, encodeId=4080e202202, content=很有用的信息,我有一问题,招募受试者是否要在完成注册之后呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5731702540, createdName=limuhan, createdTime=Sun Mar 20 20:15:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65565, encodeId=90e365565da, content=谢谢啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Feb 25 10:45:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64554, encodeId=294e6455427, content=学习了,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa5c1667132, createdName=research_2015, createdTime=Wed Feb 17 10:33:00 CST 2016, time=2016-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=53547, encodeId=bbbe5354e5d, content=很好,领导让学习,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37171668497, createdName=vv79, createdTime=Fri Jan 08 00:19:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43792, encodeId=df8a43e921c, content=是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc9a1665483, createdName=学海愚翁, createdTime=Wed Nov 25 15:14:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
    2015-11-25 学海愚翁

    是不是在中国临床试验注册中心进行注册后,中国中心会代理注册人向美国临床试验数据库进行注册?

    0

相关资讯

临床试验失败常见原因分析

                  2011-2012年共有148项II期临床试验宣布失败(包括已上市药物新适应症的I/II期研究),其中105项报告了失败原因,55%是由于疗效不足(Efficacy),28%是由于安全性问题(Safety

欧盟加速临床试验数据公开进程 AllTrials助力

在 12 月 20 日达成的临时协议下,欧盟的研究人员将不得不公开临床试验的结果。欧盟 28 个成员国的代表与欧盟议会达成协议,这是其更广泛改革的决定性一步,将会简化和加速整个欧盟的临床试验程序。让公众更容易地获取临床试验结果的倡导是一个值得称赞的谈判结果,研究人员认为这是可以推广至全球的一个范例。20 日的协议是“一个非常重要的谈判阶段所取得的神奇结果”,英国 AllTrials 活动

国内数个H7N9疫苗报临床试验

上海市新发与再现传染病研究所的徐建青教授通过监控录像介绍H7N9禽流感基因疫苗研发试验的情况。新华社记者 刘颖 摄 2月7日,上海市新发与再现传染病研究所发布消息称,他们的课题组已成功研制出针对病毒H7N9的基因疫苗,该疫苗已进入临床试验申报阶段。 不过,这并非我国首个进入临床试验申报阶段的H7N9疫苗。昨晚,新京报记者了解到,此前,至少已有北京科兴生物制品有限公司和华兰生物工程股

药物临床试验中的几个重要环节

    随着现代医药研究突飞猛进的发展,药物临床试验的研发也日渐增多。药物临床试验质量管理规范(GCP)[1]是国际公认的新药临床试验的标准。凡是以人为 对象的临床试验均应以此标准进行设计、实施、监查、记录和总结报告,以确保在科学与伦理道德两方面都符合GCP及国家政策法规的要求,既能保护受试者的权 益,又能保证其安全。维护人民的健康,是医药卫生工作者不可推卸的

药物临床试验中的随机化与盲法基本原则

 药物临床试验是以人体(病人或健康志愿者)为研究对象进行的系统性研究,其研究质量和水平的高低将直接关系到患者的健康和利益。由于药物临床试验 的特殊性,所以应尽量避免研究过程中可能出现致使药物安全性或疗效评价结果偏离真实值的偏倚。随机化与盲法就是控制偏倚的重要措施。随机化一定要配合使用 盲法才能真正地减少偏倚,对受试者用随机的方法进行分组是不完整的,只有同时实施了盲法才能称得上是完整有效的。

NEJM:早期临床试验证实重组H7N9疫苗安全有效

   2013年11月,总部位于美国Maryland的生物制药公司Novavax(诺瓦瓦克斯)首次完成了甲型禽流感H7N9病毒株实验性疫苗的早期临床试验,接种疫苗的绝大多数人群都产生了保护性抗体。 利用这种新技术,可迅速生产数百万剂量的疫苗。该研究结果以评论的形式发表在2013年11月13日的NEJM上。 1.重组甲型H7N9流感病毒样颗粒疫苗的有效性和安全性 2013年,中国出现了可感染

Baidu
map
Baidu
map
Baidu
map